Kavli Prize

Press Release


For more information:
Rebecca Stauffer
AAPS Communications Manager
[email protected]

Longtime AAPS Member and Nanoscience Leader Honored with 2024 Kavli Prize

Arlington, VA—AAPS is honored to announce that longtime member Robert S. Langer, Sc.D., FAAPS, has been recognized as one of three 2024 Kavli Prize Laureates in Nanoscience.

Langer is recognized for his development of the first nano-engineered materials for the controlled release of drug molecules. His work in this area has resulted in advancements in treatments for aggressive brain cancer, prostate cancer, and schizophrenia. Additionally, his research into small particles that contain protein antigens has been applied to the development of mRNA vaccines.

He shares in a $1 million USD prize with the other two recipients: Armand Paul Alivisatos, Ph.D., and Chad A. Mirkin, Ph.D.

Dr. Langer’s 30-year membership in AAPS has been punctuated with honors. He received AAPS’ highest honor, the Distinguished Pharmaceutical Scientist Award, in 1993, and became a Fellow of the association in 1995.

He has been an active member in the association, participating in the former Pharmaceutical and Drug Delivery Section and co-authoring articles published in Pharmaceutical Research.

“Dr. Langer has been a leader in nanoscience for many decades,” AAPS Executive Director Tina Morris, Ph.D., said. “His research has served as the foundation for new treatments in a number of areas. I’m proud to see his work in this area recognized with a Kavli Prize.”

The Norwegian Academy of Science and Letters, the Norwegian Ministry of Education and Research, and The Kavli Foundation (USA) partner to award the Kavli Prize, which honors scientists for breakthroughs in astrophysics, nanoscience and neuroscience. Three $1 million USD prizes are awarded every other year in each of the three fields. Kavli Prize Laureates are selected by the Norwegian Academy of Science and Letters based on recommendations from three independent prize committees consisting of members nominated by the Chinese Academy of Sciences, the French Academy of Sciences, the Max Planck Society of Germany, the U.S. National Academy of Sciences, and the Royal Society (UK).


American Association of Pharmaceutical Scientists (AAPS) is a 501(c)(3) non-profit association of more than 7,000 scientists and professionals employed in academia, industry, regulatory, and other research related to the pharmaceutical sciences worldwide. Its mission is to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health, which members pursue through four peer-reviewed journals and various events in person and online. www.aaps.org